PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $560,000 | -44.1% | 15,066 | +0.9% | 0.02% | -33.3% |
| Q3 2016 | $1,002,000 | +86.9% | 14,937 | -18.1% | 0.02% | +60.0% |
| Q1 2016 | $536,000 | +54.5% | 18,240 | +295.7% | 0.02% | +150.0% |
| Q3 2015 | $347,000 | -33.0% | 4,609 | +3.9% | 0.01% | -33.3% |
| Q2 2015 | $518,000 | +103.9% | 4,434 | +230.6% | 0.01% | +125.0% |
| Q4 2014 | $254,000 | -51.7% | 1,341 | -39.2% | 0.00% | -60.0% |
| Q3 2014 | $526,000 | +13.1% | 2,205 | -68.7% | 0.01% | +42.9% |
| Q2 2014 | $465,000 | -42.1% | 7,045 | -8.7% | 0.01% | -30.0% |
| Q1 2014 | $803,000 | – | 7,713 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |